Treating Chronic Hand Eczema with Upadacitinib: Insights from Clinical Trials and Real-World Experience
Journal of Drugs in Dermatology · 01.07.2025 · 24 (7) · 702-707
DOI: 10.36849/jdd.9156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.06.2025. Verfasst von Omar Alani und 11 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermatologic Agents, Eczema, Hand Dermatoses, Heterocyclic Compounds, 3-Ring. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Alani, O., Shqair, L., Liszewski, W. J., Yu, H., Draw, I., Wahood, S., Galimberti, F., Sweney, B., Obagi, S., Mastro, A., Dasilva, D., & Bunick, C. G. (2025). Treating Chronic Hand Eczema with Upadacitinib: Insights from Clinical Trials and Real-World Experience. Journal of Drugs in Dermatology, 24(7), 702-707. https://doi.org/10.36849/jdd.9156
Vancouver
Alani O, Shqair L, Liszewski WJ, Yu H, Draw I, Wahood S, et al. Treating Chronic Hand Eczema with Upadacitinib: Insights from Clinical Trials and Real-World Experience. Journal of Drugs in Dermatology. 2025;24(7):702-707. doi:10.36849/jdd.9156
BibTeX
@article{Alani2025,
author = {Alani, Omar and Shqair, Lara and Liszewski, Walter J and Yu, Henry and Draw, Iyla and Wahood, Samer and Galimberti, Fabrizio and Sweney, Beth and Obagi, Sabine and Mastro, Andrew and Dasilva, Diego and Bunick, Christopher G},
title = {Treating Chronic Hand Eczema with Upadacitinib: Insights from Clinical Trials and Real-World Experience},
journal = {Journal of Drugs in Dermatology},
year = {2025},
volume = {24},
number = {7},
pages = {702--707},
doi = {10.36849/jdd.9156}
}
EUVIMED